相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis
A. Bayas et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE
Magnus Isaksson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Cathepsins are required for toll-like receptor 9 responses
Fumi Matsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
STAT4: Genetics, mechanisms, and implications for autoimmunity
Benjamin D. Korman et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2008)
Plasmacytoid dendritic cells in multiple sclerosis:: Intracerebral recruitment and impaired maturation in response to interferon-β
Roberto Lande et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Sarah E. Ewald et al.
NATURE (2008)
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9
Boyoun Park et al.
NATURE IMMUNOLOGY (2008)
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
Satoshi Serada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Epidemiology of multiple sclerosis: From risk factors to prevention
Alberto Ascherio et al.
SEMINARS IN NEUROLOGY (2008)
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Michel Gilliet et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
Barbara Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
Altered maturation of circulating dendritic cells in primary progressive MS patients
Cristina Lopez et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis
M Stasiolek et al.
BRAIN (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
Multiple sclerosis is linked to Epstein-Barr virus infection
Sven Haahr et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9
T Ito et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Plasmacytoid dendritic cells: Linking innate and adaptive immunity
K McKenna et al.
JOURNAL OF VIROLOGY (2005)
Regulation of IFN regulatory factor-7 and IFN-α production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells
JH Dai et al.
JOURNAL OF IMMUNOLOGY (2004)
Plasmacytoid dendritic cells in immunity
M Colonna et al.
NATURE IMMUNOLOGY (2004)
Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells
A Izaguirre et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
被撤回的出版物: Multiple sclerosis and Epstein-Barr virus (Retracted Article. See vol 293, pg 2466, 2005)
LI Levin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Immunization and MS - A summary of published evidence and recommendations
OT Rutschmann et al.
NEUROLOGY (2002)
Activation of APCs through CD40 or toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease
HT Ichikawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Elevated expression of CCR5 by myeloid (CD11c(+)) blood dendritic cells in multiple sclerosis and acute optic neuritis
M Pashenkov et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genes
KP Wandinger et al.
ANNALS OF NEUROLOGY (2001)
Two subsets of dendritic cells are present in human cerebrospinal fluid
M Pashenkov et al.
BRAIN (2001)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
CPG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo
BM Segal et al.
JOURNAL OF IMMUNOLOGY (2000)